Eagle Health Investments LP Q2 2025 Filing

Filed August 12, 2025

Portfolio Value

$405.2B

Holdings

21

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (21 positions)

#StockSharesValue% PortfolioType
1
IM8NINSMED INC
428,600$43.1B10.65%
2
ARGXARGENX SE
77,430$42.7B10.53%
3
NTRANATERA INC
235,964$39.9B9.84%
4
ILMNILLUMINA INC
343,361$32.8B8.09%
5
ICLRICON PLC
202,790$29.5B7.28%
6
NBIXNEUROCRINE BIOSCIENCES INC
217,200$27.3B6.74%
7
DC4DEXCOM INC
273,821$23.9B5.90%
8
RAREULTRAGENYX PHARMACEUTICAL IN
627,600$22.8B5.63%
9
BMRNBIOMARIN PHARMACEUTICAL INC
366,812$20.2B4.98%
10
UNHUNITEDHEALTH GROUP INC
60,888$19.0B4.69%
11
PRCTPROCEPT BIOROBOTICS CORP
299,089$17.2B4.25%
12
ALNYALNYLAM PHARMACEUTICALS INC
46,086$15.0B3.71%
13
AKROAKERO THERAPEUTICS INC
226,400$12.1B2.98%
14
EXASEXACT SCIENCES CORP
223,750$11.9B2.93%
15
BBIOBRIDGEBIO PHARMA INC
259,300$11.2B2.76%
16
GHGUARDANT HEALTH INC
212,000$11.0B2.72%
17
AGIOAGIOS PHARMACEUTICALS INC
330,830$11.0B2.72%
18
SRRKSCHOLAR ROCK HLDG CORP
269,400$9.5B2.36%
19
ISRGINTUITIVE SURGICAL INC
4,390$2.4B0.59%
20
IMCRIMMUNOCORE HLDGS PLC
46,300$1.5B0.36%
21
VIRVIR BIOTECHNOLOGY INC
240,500$1.2B0.30%